- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
XORTX Therapeutics, a company that develops therapies to inhibit the production of uric acid, has applied for listing on the Nasdaq.
What's in this guide?
Our top picks for where to buy XORTX Therapeutics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy XORTX Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – XRTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy XORTX Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
XORTX Therapeutics stock price (NASDAQ: XRTX)
Use our graph to track the performance of XRTX stocks over time.XORTX Therapeutics shares at a glance
Information last updated 2024-10-25.
| Latest market close | $1.52 |
|---|---|
| 52-week range | $1.09 - $29.89 |
| 50-day moving average | $1.69 |
| 200-day moving average | $2.42 |
| Wall St. target price | $12.08 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.37 |
Is it a good time to buy XORTX Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
XORTX Therapeutics price performance over time
Historical closes compared with the close of $1.555 from 2024-10-28
| 1 week (2024-10-23) | -1.58% |
|---|---|
| 1 month (2024-09-30) | -5.18% |
| 3 months (2024-07-30) | -11.14% |
| 6 months (2024-04-30) | -39.02% |
| 1 year (2023-10-30) | 427.12% |
|---|---|
| 2 years (2022-10-28) | 85.12% |
| 3 years (2021-10-29) | 2.82 |
| 5 years (2019-10-26) | N/A |
XORTX Therapeutics financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -33.14% |
| Return on equity TTM | -29.36% |
| Profit margin | 0% |
| Book value | $0.93 |
| Market Capitalization | $5.2 million |
TTM: trailing 12 months
XORTX Therapeutics share dividends
We're not expecting XORTX Therapeutics to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (5.82% forward annual dividend yield)
- Johnson-and-Johnson (JNJ.US) (2.99% forward annual dividend yield)
Have XORTX Therapeutics's shares ever split?
XORTX Therapeutics's shares were split on a 1:9 basis on 13 November 2023 . So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your XORTX Therapeutics shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for XORTX Therapeutics shares which in turn could have impacted XORTX Therapeutics's share price.
XORTX Therapeutics share price volatility
Over the last 12 months, XORTX Therapeutics's shares have ranged in value from as little as $1.09 up to $29.889. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XORTX Therapeutics's is -0.186. This would suggest that XORTX Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, XORTX Therapeutics has bucked the trend.
To put XORTX Therapeutics's beta into context you can compare it against those of similar companies.
- Biogen (BIIB.US): -0.06
- Pfizer (PFE.US): 0.617
- Johnson-and-Johnson (JNJ.US): 0.518
XORTX Therapeutics overview
XORTX Therapeutics Inc. , a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, a program to treat acute kidney injury (AKI) associated with respiratory virus infection and associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. It has a collaboration and license agreements with the Icahn School of Medicine; and a license agreement with the University of Florida Research Foundation, Inc. The company is based in Alberta Beach, Canada. .
Frequently asked questions
What percentage of XORTX Therapeutics is owned by insiders or institutions?Currently 3.349% of XORTX Therapeutics shares are held by insiders and 6.373% by institutions. How many people work for XORTX Therapeutics?
Latest data suggests 2 work at XORTX Therapeutics. When does the fiscal year end for XORTX Therapeutics?
XORTX Therapeutics's fiscal year ends in December. Where is XORTX Therapeutics based?
XORTX Therapeutics's address is: 3710 ? 33rd Street NW, Alberta Beach, AB, Canada, T2L 2M1 What is XORTX Therapeutics's ISIN number?
XORTX Therapeutics's international securities identification number is: CA98420Q2071
More resources on Finder
More guides on Finder
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question